Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010032/S260

Proclaim family of SCS IPG

ABBOTT MEDICAL · Decision date Sep 23, 2026

MEDTECHLEDGER EXPLANATIONP010032/S260

What did the FDA approve?

FDA database entry P010032/S260 records an approval dated 2026-09-23 for a material change to the encapsulant used in the printed circuit board assembly during manufacture of the Proclaim Spinal Cord Stimulator, Proclaim Dorsal Root Ganglion stimulator, and Infinity Deep Brain Stimulator Implantable Pulse Generator devices. The applicant is Abbott Medical, and the supplement type is Real-Time Process with the stated reason 'Change Design/Components/Specifications/Material.'

This supplement is not a new approval of the whole system. The source statement reports the purpose of the change but does not provide independent proof of safety or clinical effectiveness. Specific information absent from the record includes the previous and new encapsulant materials, the manufacturing site, and any supporting test data.

FDA approval order statement

approval for a material change to the encapsulant used in the printed circuit board assembly (PCBA) during the manufacture of the Proclaim Spinal Cord Stimulator (SCS), Proclaim Dorsal Root Ganglion (DRG) stimulator and Infinity Deep Brain Stimulator (DBS) Implantable Pulse Generator (IPG) devices.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Neurology
Decision date
Sep 23, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P010032/S260
Regulatory pathway
PMA supplement
Product code
LGW
Decision code
APPR
Decision date
Sep 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.

Product code
LGW
FDA device class
3

For the original device and its historical approval scope, see PMA P010032. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010032 · Original PMA

    GENESIS AND EON FAMILY NEUROSTIMULATION (IPG) SYSTEMS

  2. P010032/S260 received

    Application receipt date recorded by FDA.

  3. P010032/S261 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger

  4. P010032/S251 · Related supplement

    Quattrode; Octrode; Penta; Lamitrode; Tripole; TriCentrus Lead Extensions

  5. P010032/S260 · FDA decision

    Real-Time Process

  6. P010032/S265 · Related supplement

    Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generator

  7. P010032/S262 · Related supplement

    Spinal Cord Stimulation (SCS) External Pulse Generator (EPG)

  8. P010032/S264 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger

  9. P010032/S266 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)

Timeline entries are records held by MedtechLedger for P010032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010032

Explore the linked device profile

Other records with product code LGW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6901 Preston Rd., Plano, TX, 75024

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records